The insider selling is trivial in size and likely tied to equity grant vesting, not a negative signal. Monitor for any upcoming earnings or pipeline catalysts that could move the stock, but this cluster alone does not warrant action.
Price Chart
Executive Summary
A cluster of insider selling at Xeris Biopharma, totaling $192K in open-market sales by two directors and an officer, occurred alongside large non-cash equity grants to four directors. The sales represent ~0.017% of the $1.1B market cap, a trivial amount, and are likely liquidity-driven following the vesting of restricted stock grants. No material bearish signal is present.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $192K in open-market sales: Director John Johnson ($91K), Director Dawn Halkuff ($122K), and Officer Beth Hecht ($101K).
- Four directors received non-cash equity grants totaling ~$609K in value (at $6.15/share) and additional zero-value grants.
- Total open-market sales represent ~0.017% of the $1.1B market cap, well below the 0.1% threshold for materiality.
- Sales occurred on the same day as large equity grants, suggesting a routine pattern of selling to cover tax obligations or diversify after vesting.
Financial Impact
Open-market sales of $192K, or ~0.017% of market cap, are immaterial relative to company size.
Risk Factors
- No material risk identified from this insider activity; the cluster is routine and non-informative.
- The company's historical insider report win rate is 50% with negative average alpha, suggesting past cluster reads have not been predictive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1780697908162 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $7.71 $7.78 | ▲ +0.91% | ▲ +1.56% | $9.08 (+17.77%) |
Sep 1, 2026 4w ago | Insider Cluster | $8.58 $7.67 | ▼ −10.61% | ▼ −9.65% | $9.08 (+5.83%) |
Aug 6, 2026 8w ago | 8-K | $7.36 $8.33 | ▲ +13.18% | ▲ +11.97% | $9.08 (+23.37%) |
Aug 4, 2026 8w ago | Insider Cluster | $8.19 $8.39 | ▲ +2.44% | ▲ +2.54% | $9.08 (+10.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $8.94 $8.28 | ▲ +7.38% | ▲ +7.93% | $9.08 (−1.57%) |
Jul 2, 2026 13w ago | 3 | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jul 2, 2026 13w ago | Insider Cluster | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jun 30, 2026 13w ago | 8-K | $8.00 $8.94 | ▲ +11.75% | ▲ +11.49% | $9.08 (+13.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $6.79 $6.95 | ▲ +2.36% | ▲ +1.68% | $9.08 (+33.73%) |
Jun 5, 2026 16w ago | Insider Cluster | $6.24 $6.88 | ▲ +10.26% | ▲ +8.14% | $9.08 (+45.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access